Navigation Links
Eisai Oncology to Present New Research on Eribulin at 35th Annual San Antonio Breast Cancer Symposium
Date:11/28/2012

tuzumab as first-line therapy for locally recurrent or metastatic HER2-positive breast cancer: results from a Phase II, multicenter, single-arm study

Poster SessionEribulin Mesylate

Abstract No:

P1-13-11Adjuvant treatment of early-stage breast cancer with eribulin mesylate following dose-dense doxorubicin and cyclophosphamide: preliminary results from a Phase II, single-arm feasibility study Poster SessionEribulin Mesylate

Abstract No.

P6-11-14Post-hoc safety and tolerability assessment in patients receiving palliative radiation during treatment with eribulin mesylate for metastatic breast cancer

Poster SessionN/A

Abstract No:

P6-09-06Family Members' Burden in Patients with Metastatic and Early Stage Breast Cancer

Poster SessionThe information discussed in this release is about investigational uses for an FDA-approved product. It is not intended to convey conclusions of efficacy and safety.

About Halaven
Halaven is indicated for the treatment of patients with metastatic breast cancer who have previously received at least two chemotherapeutic regimens for the treatment of metastatic disease. Prior therapy should have included an anthracycline and a taxane either in the adjuvant or metastatic setting. 

Important Safety Information about HalavenDecreased White Blood Cells (Neutropenia)
A doctor should do a blood test to monitor a patient's blood cells before they receive each dose of Halaven, and should monitor them more often if they develop lower white blood cells. If a patient develops severe neutropenia lasting longer than 7 days or neutropenia with a fever, their next dose of Halaven should be delayed and reduced. Severe neutropenia occurred in 57% (287/503) of patients who received Halaven and lasted more than 1 week in 12% (62/503) of patients. Neutropenia with a fever occurred in 5% (23/503) of patients; 2 patients died from compl
'/>"/>

SOURCE Eisai Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Eisai USA Foundation to Donate $100,000 to the Hurricane Sandy New Jersey Relief Fund, $50,000 to the American Red Cross
2. Epilepsia Publishes Results From Two Studies Of Eisais Perampanel
3. Shaji Procida Appointed Vice President and Chief Financial Officer of Eisai Inc.
4. Eisai Oncology to Present New Research on Product Portfolio and Pipeline at ASCO Annual Meeting
5. Gynecologic Oncology Publishes New Clinical Study Showing Positive Performance of OVA1, Vermillions Ovarian Cancer Test
6. More Practices Join RainTree Oncology Network As Company Expands Presence In Community Oncology
7. The Oncology Nurse Community To Host Live Webinar On Cancer Pain Management
8. Cerulean Pharmas Lead Candidate Selected as a "Top 10 Oncology Project to Watch"
9. MEI Pharmas Mitochondrial Inhibitor Drug Candidate ME-344 Named One of Top 10 Oncology Products for 2012
10. United States Oncology Drug Delivery Preferences and Opportunities in Cancer Drug Delivery
11. DelMar Pharmaceuticals to Present Interim Clinical Data on VAL-083 in Refractory Glioblastoma at Society for Neuro-Oncology (SNO) Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... 19, 2014   Lincor Inc. today ... technology to New Jersey -based ... CarePoint Health will deploy Lincor,s PatientLINC technology across ... Hospital and Hoboken University Medical Center. ... software solutions to help hospitals reach new levels ...
(Date:8/19/2014)...  The Alabama Supreme Court, in a 6-3 decision on ... who mislead doctors into believing that prescription medicines the companies ... v. Wyeth, and the decision came after the Supreme Court ... year. Heninger Garrison Davis attorneys Lew Garrison and ... Danny Weeks . The decision won a ...
(Date:8/19/2014)... , Aug. 19, 2014 Talyst, a market ... exhibiting at the 2014 NPPA Summer Conference in ... be showcasing its 340B software products and services.   ... splitting solutions, supplying over 400 customers with a variety ... 340B solutions including its latest solution, AutoSplit® Contract Pharmacy ...
Breaking Medicine Technology:Lincor Announces Agreement With CarePoint Health For State-Of-The-Art Patient Engagement Technology 2Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 2Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 3Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 4Talyst Exhibits at the NPPA Summer Conference 2
(Date:8/19/2014)... The National Cannabis Industry Association ... Symposium on Saturday, August 23, from 9:45am to ... Vegas. , Featuring keynotes by U.S. Representative Dina Titus ... the event will also include in-depth discussions on marijuana-infused ... doing federally to advance a legitimate and responsible cannabis ...
(Date:8/19/2014)... Plains, NY (PRWEB) August 19, 2014 ... they were named the winner of the 2014 ... Naturals took home the first place position in ... the marketplace specially-formatted eyeliner, which also includes a ... rich black color, plus lash-boosting technology. ...
(Date:8/19/2014)... 19, 2014 Just back from Glasgow where ... Booklets at the Commonwealth Games (July 23 – August ... kids stay off drugs. And the need for his work ... 850,000 people age16 to 59 consumed Class A drugs within ... abusing New Psychoactive Substances (NPS) drugs considered to be “legal ...
(Date:8/19/2014)... stay and could use this time as an opportunity to ... home. Now a study published in the August 20 ... the proportion of hospitalized smokers who successfully quit smoking after ... interactive voice response technology automated telephone calls to ... left the hospital. , "Most smokers want to ...
(Date:8/19/2014)... Program has selected three geriatric social work ... development and mentorship for projects that will improve ... for all older adults. , The 2014 Hartford/VA ... among veterans, transitions from VA nursing facilities back ... older veterans. The Hartford/VA Geriatric Scholars Program provides ...
Breaking Medicine News(10 mins):Health News:SATURDAY IN LAS VEGAS: U.S. Rep. Dina Titus, State Sen. Tick Segerblom Keynote National Cannabis Industry Association Southwest CannaBusiness Symposium 2Health News:GrandeLINER™ Wins Independent Cosmetics Manufacturers & Distributors Award 2Health News:GrandeLINER™ Wins Independent Cosmetics Manufacturers & Distributors Award 3Health News:British Scientologist on a Mission to Save Youth from Drug Abuse 2Health News:Extended support helps patients stay smoke-free after hospital discharge 2
... The Kerlan Jobe Orthopaedic Clinic, a sports medicine clinic in ... million to settle allegations that it received illegal kickbacks from ... , The settlement resolves allegations that HealthSouth paid ... grants, donations to the Kerlan Jobe Foundation, loan forgiveness on ...
... , LOS ANGELES, Dec. 1 A decision issued ... Board (NLRB) has put at risk the guaranteed raises, healthcare ... professionals in Southern California. , "We have worked for years ... allow us to provide the professional care our patients need," ...
... tomography (CT) imaging of changes in tumors from colorectal ... have the potential to predict overall survival, according to ... JAMA . The addition of bevacizumab to ... survival in patients with stage IV colorectal cancer and ...
... , , ... (ASH) will host its annual High School Student Symposium at ... a.m. CST. The symposium, which encourages an interest in hematology, ... with the Society,s 51st Annual Meeting. This year, students will ...
... , MEXICO CITY, Dec. 1 ... will build a world-class center for biomedical and nanomedical ... research and development will be integrated with the National ... in the world. The research complex, scheduled to ...
... , BELLEVUE, Wash., Dec 1 Edifecs, ... Channel Modernization solutions announced an enhanced release of Edifecs ... migrations. XEngine Translator provides out-of-the-box 4010A1-5010 conversion maps, allows ... 4010A1 and 5010 in production, thus addressing most requirements ...
Cached Medicine News:Health News:Los Angeles' Kerlan Jobe Orthopaedic Clinic Pays $3 Million to Settle Kickback Allegations 2Health News:Labor Board Decision Puts Kaiser Workers' Pay, Healthcare, Pensions in Jeopardy 2Health News:Criteria based on CT imaging after chemotherapy may help predict survival 2Health News:ASH to Encourage High School Students to Pursue Biomedical Research Through Special Symposium and Science Curriculum 2Health News:ASH to Encourage High School Students to Pursue Biomedical Research Through Special Symposium and Science Curriculum 3Health News:Mexico City to Build World-Class Hub for Medical Research 2Health News:Edifecs Delivers Enhanced HIPAA 4010A1 to 5010 Migration Capabilities for Healthcare Organizations 2Health News:Edifecs Delivers Enhanced HIPAA 4010A1 to 5010 Migration Capabilities for Healthcare Organizations 3
The ACMI TurboFlow 18 L and 10 L Insufflators provide rapid distention for all laparoscopic procedures. Eleven built-in safety features make insufflation reliable and dependable....
This multiple-function instrument allows the surgeon to grasp, coagulate, and transect tissue with a single instrument, eliminating the need for multiple instruments and, in some procedures, costly l...
Bipolar forceps...
... An in vitro Nucleic Acid ... using Microplate Chemiluminescence for the ... (HPV) Types 6,11,16,18,31,33,35,39,42,43,44,45,51,52,56,58,59 and 68 ... Lowand High-Risk Groups in Cervical ...
Medicine Products: